References
- Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:https://doi.org/10.1016/j.jaci.2003.09.008.
- Ko FW, Hui DS, Leung TF, Chu HY, Wong GW, Tung AH, Ngai JC, Ng SS, Lai CK. Evaluation of the asthma control test: A reliable determinant of disease stability and a predictor of future exacerbations. Respirology. 2012;17(2):370–378. doi:https://doi.org/10.1111/j.1440-1843.2011.02105.x.
- Wei HH, Zhou T, Wang L, Zhang HP, Fu JJ, Wang L, Ji YL, Wang G. Current asthma control predicts future risk of asthma exacerbation: a 12-month prospective cohort study. Chin Med J. 2012;125:2986–2993.
- Tay TR, Radhakrishna N, Hore-Lacy F, Smith C, Hoy R, Dabscheck E, Hew M. Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life. Respirology. 2016;21(8):1384–1390. doi:https://doi.org/10.1111/resp.12838.
- Ahmed AE, Al-Jahdali H, Al-Harbi A, Khan M, Ali Y, Al Shimemeri A, Al-Muhsen S, Halwani R. Factors associated with poor asthma control among asthmatic patient visiting emergency department. Clin Respir J. 2014;8(4):431–436. doi:https://doi.org/10.1111/crj.12090.
- Zhong N, Lin J, Zheng J, Lai K, Xie C, Tang KJ, Huang M, Chen P, Wang C. Uncontrolled asthma and its risk factors in adult Chinese asthma patients. Therap Adv Resp. 2016;10(6):507–517. doi:https://doi.org/10.1177/1753465816663978.
- Dick S, Doust E, Cowie H, Ayres JG, Turner S. Associations between environmental exposures and asthma control and exacerbations in young children: a systematic review. BMJ Open. 2014;4(2):e003827. doi:https://doi.org/10.1136/bmjopen-2013-003827.
- Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H, LIAISON Study Group. Determinants and impact of suboptimal asthma control in Europe: The International Cross-Sectional and Longitudinal Assessment on Asthma Control (LIAISON) study. Respir Res. 2016;17(1):51. doi:https://doi.org/10.1186/s12931-016-0374-z.
- Lee LK, Obi E, Paknis B, Kavati A, Chipps B. Asthma control and disease burden in patients with asthma and allergic comorbidities. J Asthma. 2018;55(2):208–219. doi:https://doi.org/10.1080/02770903.2017.1316394.
- Sá-Sousa A, Almeida R, Vicente R, Nascimento N, Martins H, Freitas A, Fonseca JA. High oral corticosteroid exposure and overuse of short‐acting beta‐2‐agonists were associated with insufficient prescribing of controller medication: a nationwide electronic prescribing and dispensing database analysis. Clin Transl Allergy. 2019;9(1):47. doi:https://doi.org/10.1186/s13601-019-0286-3.
- Ekström M, Nwaru BI, Hasvold P, Wiklund F, Telg G, Janson C. Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden. Allergy. 2019;74(11):2181–2190. doi:https://doi.org/10.1111/all.13874.
- Coban H, Aydemir Y. The relationship between allergy and asthma control, quality of life, and emotional status in patients with asthma: a cross-sectional study. Allergy Asthma Clin Immunol. 2014;10(1):67.
- Li Y, Jiang Q, Ji Y, Cao C. Anxiety and depression may associate with poorer control and quality of life in adults with asthma. Allergy. 2020;75(7):1759–1762. doi:https://doi.org/10.1111/all.14189.
- Witusik A, Witusik A, Mokros Ł, Kosmalski M, Panek M, Nowakowska-Domagała K, Sipowicz K, Kuna P, Pietras T. Type D personality and the degree of control of bronchial asthma. Postepy Dermatol Alergol. 2018;35(4):387–391. doi:https://doi.org/10.5114/ada.2018.77670.
- Axelsson M, Emilsson M, Brink E, Lundgren J, Torén K, Lötvall J. Personality, adherence, asthma control and health-related quality of life in young adult asthmatics. Respir Med. 2009;103(7):1033–1040. doi:https://doi.org/10.1016/j.rmed.2009.01.013.
- Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). 2019. Available from: https://www.ginasthma.org/.
- Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47(2):76–83. doi:https://doi.org/10.1136/thx.47.2.76.
- Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997;27(1):191–197. doi:https://doi.org/10.1017/s0033291796004242.
- Choynowski M. The development of the Polish adaptation of the Eysenck's “Maudsley personality inventory”. Acta Psychol (Amst). 1969;31:45–65. doi:https://doi.org/10.1016/0001-6918(69)90071-7.
- Chiesi F, Galli S, Primi C, Innocenti Borgi P, Bonacchi A. The accuracy of the Life Orientation Test-Revised (LOT-R) in measuring dispositional optimism: evidence from item response theory analyses. J Pers Assess. 2013;95(5):523–529. doi:https://doi.org/10.1080/00223891.2013.781029.
- Juczynski Z. Measurement tools in the promotion and psychology of health. Warsaw: Pracownia Testów Psychologicznych; 2009:164.
- Tomisa G, Horváth A, Szalai Z, Müller V, Tamási L. Prevalence and impact of risk factors for poor asthma outcomes in a large, specialist-managed patient cohort: a real-life study. JAA. 2019;12:297–307. doi:https://doi.org/10.2147/JAA.S211246.
- Pedersen SE, Prasad N, Goehring UM, Andersson H, Postma DS. Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day. JAA. 2017;10:35–46. doi:https://doi.org/10.2147/JAA.S111712.
- Broersen LH, Pereira AM, Jørgensen JO, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(6):2171–2180. doi:https://doi.org/10.1210/jc.2015-1218.
- Bengtson LGS, Yu Y, Wang W, Cao F, Hulbert EM, Wolbeck R, Elliott CA, Buikema AR. Inhaled corticosteroid-containing treatment escalation and outcomes for patients with asthma in a U.S. health care organization. J Manag Care Spec Pharm. 2017;23:1149–1159.
- Vähätalo I, Ilmarinen P, Tuomisto LE, Niemelä O, Kankaanranta H. Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study. Respir Med. 2018;137:70–76. doi:https://doi.org/10.1016/j.rmed.2018.02.025.
- Heaney LG, Conway E, Kelly C, Johnston BT, English C, Stevenson M, Gamble J. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax. 2003;58(7):561–566. doi:https://doi.org/10.1136/thorax.58.7.561.
- Sullivan SD, Wenzel SE, Bresnahan BW, Zheng B, Lee JH, Pritchard M, Kamath TV, Weiss ST. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy. 2007;62(6):655–660. doi:https://doi.org/10.1111/j.1398-9995.2007.01383.x.
- Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. doi:https://doi.org/10.1016/j.jaci.2014.08.042.
- Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014;371(13):1189–1197. doi:https://doi.org/10.1056/NEJMoa1403291.
- Gibson PG, Reddel H, McDonald VM, Marks G, Jenkins C, Gillman A, Upham J, Sutherland M, Rimmer J, Thien F, et al. Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry. Intern Med J. 2016;46(9):1054–1062. doi:https://doi.org/10.1111/imj.13166.
- Stanford RH, Shah MB, D'Souza AO, Dhamane AD, Schatz M. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Ann Allergy Asthma Immunol. 2012;109(6):403–407. doi:https://doi.org/10.1016/j.anai.2012.08.014.
- Shlomi D, Katz I, Segel MJ, Oberman B, Peled N. Determination of asthma control using administrative data regarding short-acting beta-agonist inhaler purchase. J Asthma. 2018;55(5):571–577. doi:https://doi.org/10.1080/02770903.2017.1348513.
- Cajigal S, Wells KE, Peterson EL, Ahmedani BK, Yang JJ, Kumar R, Burchard EG, Williams LK. Predictive properties of the asthma control test and its component questions for severe asthma exacerbations. J Allergy Clin Immunol Pract. 2017;5(1):121–127. doi:https://doi.org/10.1016/j.jaip.2016.06.025.
- Bennett GH, Carpenter L, Hao W, Song P, Steinberg J, Baptist AP. Risk factors and clinical outcomes associated with fixed airflow obstruction in older adults with asthma. Ann Allergy Asthma Immunol. 2018;120(2):164–168. doi:https://doi.org/10.1016/j.anai.2017.10.004.
- Matsunaga K, Ichikawa T, Oka A, Morishita Y, Kanai K, Hiramatsu M, Akamatsu H, Kawabata H, Kikuchi T, Akamatsu K, et al. Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline. Respir Med. 2014;108(7):976–982. doi:https://doi.org/10.1016/j.rmed.2014.04.014.
- Kwon JW, Jung H, Kim SH, Chang YS, Cho YS, Nahm DH, Jang AS, Park JW, Yoon HJ, Cho SH, et al. COREA investigators. High ACT score is not sufficient to reduce the risk of asthma exacerbations in asthma with low lung function. Respir Med. 2019;150:38–44. doi:https://doi.org/10.1016/j.rmed.2019.02.010.
- Tay TR, Hew M. Comorbid “treatable traits” in difficult asthma: current evidence and clinical evaluation. Allergy. 2018;73(7):1369–1382. doi:https://doi.org/10.1111/all.13370.
- Liang B, Yi Q, Feng Y. Association of gastroesophageal reflux disease with asthma control. Dis Esophagus. 2013;26(8):794–798. doi:https://doi.org/10.1111/j.1442-2050.2012.01399.x.
- Denlinger LC, Phillips BR, Ramratnam S, Ross K, Bhakta NR, Cardet JC, Castro M, Peters SP, Phipatanakul W, Aujla S, et al. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations. Am J Respir Crit Care Med. 2017;195(3):302–313. doi:https://doi.org/10.1164/rccm.201602-0419OC.
- Temam S, Chanoine S, Bédard A, Dumas O, Sanchez M, Boutron-Ruault MC, Siroux V, Rican S, Varraso R, Le Moual N. Low socioeconomic position and neighborhood deprivation are associated with uncontrolled asthma in elderly. Respir Med. 2019;158:70–77. doi:https://doi.org/10.1016/j.rmed.2019.09.010.
- de Vries MP, van den Bemt L, Lince S, Muris JW, Thoonen BP, van Schayck CP. Factors associated with asthma control. J Asthma. 2005;42(8):659–665. doi:https://doi.org/10.1080/02770900500264903.
- Ilmarinen P, Juboori H, Tuomisto LE, Niemelä O, Sintonen H, Kankaanranta H. Effect of asthma control on general health-related quality of life in patients diagnosed with adult-onset asthma. Sci Rep. 2019;9(1):16107. doi:https://doi.org/10.1038/s41598-019-52361-9.
- González-Freire B, Vázquez I, Pértega-Díaz S. The relationship of psychological factors and asthma control to health-related qquality of life. J Allergy Clin Immunol Pract. 2020;8(1):197–207. doi:https://doi.org/10.1016/j.jaip.2019.07.009.
- Lavoie KL, Bacon SL, Barone S, Cartier A, Ditto B, Labrecque M. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest. 2006;130(4):1039–1047. doi:https://doi.org/10.1378/chest.130.4.1039.
- Sundbom F, Malinovschi A, Lindberg E, Almqvist C, Janson C. Insomnia symptoms and asthma control-Interrelations and importance of comorbidities. Clin Exp Allergy. 2020;50(2):170–177. doi:https://doi.org/10.1111/cea.13517.
- Luyster FS, Strollo PJ, Jr, Holguin F, Castro M, Dunican EM, Fahy J, Gaston B, Israel E, Jarjour NN, Mauger DT, et al. Association between insomnia and asthma burden in the severe asthma research program (SARP) III. Chest. 2016;150(6):1242–1250. doi:https://doi.org/10.1016/j.chest.2016.09.020.
- Lavietes MH. The interpretation of dyspnea in the patient with asthma. Pulm Med. 2015;2015:869673. doi:https://doi.org/10.1155/2015/869673.
- Rona RJ, Smeeton NC, Amigo H, Vargas C. Do psychological distress and somatization contribute to misattribution of asthma? A Chilean study. J Psychosom Res. 2007;62(1):23–30. doi:https://doi.org/10.1016/j.jpsychores.2006.07.015.
- van der Molen T, Fletcher M, Price D. Identifying patient attitudinal clusters associated with asthma control: the European REALISE survey. J Allergy Clin Immunol Pract. 2018;6(3):962–971. doi:https://doi.org/10.1016/j.jaip.2017.10.007.
- Snadden D, Brown JB. The experience of asthma. Soc Sci Med. 1992;34(12):1351–1361. doi:https://doi.org/10.1016/0277-9536(92)90144-f.
- Cheung MM, LeMay K, Saini B, Smith L. Does personality influence how people with asthma manage their condition? J Asthma. 2014;51(7):729–736. doi:https://doi.org/10.3109/02770903.2014.910220.
- Sastre J, Crespo A, Fernandez-Sanchez A, Rial M, Plaza V, González FC, López JJ, Riaza MM, Orenes MM, Montaño PP, et al. Anxiety, depression, and asthma control: changes after standardized treatment. J Allergy Clin Immunol Pract. 2018;6(6):1953–1959. doi:https://doi.org/10.1016/j.jaip.2018.02.002.